skip to content

Department of Chemical Engineering and Biotechnology

 

The success of the Department’s spinout companies is tangible; the following companies are representative of those founded by our staff:

EnVal Ltd won the materials/chemistry European ACES Award (2011), the National Recycling Award (2011) and the Finance for the Future Award (2013).

ProMetic BioSciences Ltd/Inc is a publicly listed company on the Toronto Stock Exchange active in the area of oral therapeutics and protein technologies and with a current market capitalisation of $CDN 500M.

Psynova Neurotech Ltd has featured in Business Week and has won the Medical Futures Innovation Award for a business in the Neuroscience sector and more recently, was nominated as the best bioscience spin-out company in Europe (2011), prior to being acquired by Myriad Genetics Inc.  

Smart Holograms Ltd was nominated the fastest growing company in the UK in 2006 and has featured in numerous trade magazines, daily newspapers and the Sunday Times Magazine. It achieved third position in the Telegraph top 50 University spinouts.

Clinical Translation

Research under the Healthcare Biotechnology theme has led to a number of entrepreneurial therapeutic and diagnostic interventions in clinical medicine. Psynova Neurotech Ltd was the first company in the world to introduce a biochemical test for schizophrenia and is currently investigating a range of biomarkers for a generic ‘neuropsychiatric disorder’ test to distinguish all major types of mental disorder. Cambridge Sensors Ltd has transformed from a blood glucose test company into a medical device company with a focus on diabetes and now sells insulin pen needles, hypoglycaemia gels, lancets and disinfection products in addition to Microdot® blood glucose systems.    ProMetic BioSciences is developing therapeutics to treat blood-related disorders and is a world-leading technology provider and drug developer in the fields of haematology, oncology and nephrology.

Graduate Student Commercial Activities

Students from the MBE and other courses participate in local, national and international business plan competitions and have established a number of spin-out companies over the 12 or so years the course has run. Successful consultancy companies include Costello Medical Consulting which provides specialised market access and medical communication services to the pharmaceutical industry and now employs 45 people in Cambridge and Hybridigm Consulting in Malaysia. CamStent, a medical materials company based in Cambridge, has completed several rounds of funding. More recently, Desktop Genetics Ltd, a bioinformatics company founded by three graduates of the MBE course has recently raised £375,000 in venture funding together with a £100,000 Technology Strategy Board grant.

Latest news

Dr Jenny Molloy named Fellow of the World Economic Forum’s Global Future Council on Synthetic Biology

12 October 2020

Shuttleworth Fellow Jenny Molloy, who leads our Open Bioeconomy Lab, was appointed in the recent call and will sit on the Global Future Council on Synthetic Biology for the next year.

CEB entrepreneur shines at climate tech competition with air pollution sensor network

24 September 2020

As one of three winners of the Women4Climate Tech Challenge, Lorena Gordillo-Dagallier secures funding and support to pilot her project in Stockholm and Lisbon

Katherine Smart makes brewing history as the first woman to be appointed as Renter Warden of the Worshipful Company of Brewers

27 August 2020

Our Lecturer in Brewing and Distilling Science and Diageo’s expert brewer, Katherine Smart, is the first woman to be appointed Renter Warden of one of the oldest of the City guilds or livery companies.